{
  "primary": "Caspase-1",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "Caspase-1 is a primary mediator of ATXN3 cleavage during apoptosis, generating a toxic fragment containing the polyQ tract that is prone to aggregation.",
  "functions": [
    {
      "function": "Proteolytic Cleavage and Generation of Toxic Fragments",
      "arrow": "activates",
      "cellular_process": "In response to apoptotic stimuli, activated Caspase-1 directly cleaves ATXN3. This proteolytic event separates the N-terminal Josephin domain from a C-terminal fragment that contains the pathogenic polyglutamine (polyQ) tract.",
      "effect_description": "The cleavage of polyQ-expanded ATXN3 by Caspase-1 is a critical pathogenic event in SCA3. It generates a smaller, C-terminal toxic fragment that is more prone to misfolding and aggregation than the full-length protein, thereby accelerating the formation of neuronal inclusions and enhancing cytotoxicity.",
      "biological_consequence": [
        "Apoptotic signaling cascade → Activation of initiator and executioner caspases, including Caspase-1 → Caspase-1 recognizes and cleaves ATXN3 at specific aspartate residues → Release of a C-terminal fragment containing the expanded polyQ tract → Increased propensity of the toxic fragment to aggregate → Formation of neuronal intranuclear inclusions → Enhanced cellular toxicity and neurodegeneration"
      ],
      "specific_effects": [
        "Caspase-1 is a primary mediator of ATXN3 cleavage in apoptotic cellular models.",
        "The cleavage results in an approximately 28-kDa C-terminal fragment containing the polyglutamine repeat.",
        "Inhibitors of Caspase-1 are highly effective at blocking ATXN3 proteolysis during apoptosis.",
        "Caspase-mediated cleavage of polyQ-expanded ATXN3 leads to increased protein aggregation."
      ],
      "evidence": [
        {
          "paper_title": "Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3",
          "journal": "Neurobiology of Disease",
          "year": 2004,
          "relevant_quote": "Using cellular models we now show that the endogenous spinocerebellar ataxia type-3 disease protein, ataxin-3, is proteolyzed in apoptotic paradigms, resulting in the loss of full-length ataxin-3 and the corresponding appearance of an approximately 28-kDa fragment containing the glutamine repeat. Broad-spectrum caspase inhibitors block ataxin-3 proteolysis and studies suggest that caspase-1 is a primary mediator of cleavage.",
          "pmid": "15140190"
        }
      ],
      "pmids": [
        "15140190"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation"
    }
  ],
  "arrow": "regulates",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": null,
  "mechanism": "In response to apoptotic stimuli, activated Caspase-1 directly cleaves ATXN3. This proteolytic event separates the N-terminal Josephin domain from a C-terminal fragment that contains the pathogenic polyglutamine (polyQ) tract.",
  "effect": "The cleavage of polyQ-expanded ATXN3 by Caspase-1 is a critical pathogenic event in SCA3. It generates a smaller, C-terminal toxic fragment that is more prone to misfolding and aggregation than the full-length protein, thereby accelerating the formation of neuronal inclusions and enhancing cytotoxicity.",
  "summary": "ATXN3 activates Caspase-1 to modulate proteolytic cleavage and generation of toxic fragments, ultimately affecting enhanced cellular toxicity and neurodegeneration.",
  "evidence": [
    {
      "paper_title": "Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3",
      "journal": "Neurobiology of Disease",
      "year": 2004,
      "relevant_quote": "Using cellular models we now show that the endogenous spinocerebellar ataxia type-3 disease protein, ataxin-3, is proteolyzed in apoptotic paradigms, resulting in the loss of full-length ataxin-3 and the corresponding appearance of an approximately 28-kDa fragment containing the glutamine repeat. Broad-spectrum caspase inhibitors block ataxin-3 proteolysis and studies suggest that caspase-1 is a primary mediator of cleavage."
    }
  ],
  "pathways": [
    {
      "name": "Apoptosis and Proteolytic Cleavage",
      "canonical_name": "Apoptosis",
      "ontology_id": "GO:0006915",
      "ontology_source": "GO",
      "confidence": 0.9
    }
  ],
  "interaction_effect": "regulation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--regulates-- Caspase-1:",
  "protein_a": "ATXN3",
  "protein_b": "Caspase-1",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-29T18:36:19.041096Z",
  "last_updated": "2025-11-29T18:36:19.041096Z"
}